Abacavir lamivudine contraindications: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Abacavir lamivudine}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== EPZICOM Tablets are contraindicated in patients with: *previously demonstrated hypersensitivit..." |
|||
| Line 6: | Line 6: | ||
EPZICOM Tablets are contraindicated in patients with: | EPZICOM Tablets are contraindicated in patients with: | ||
*previously demonstrated hypersensitivity to abacavir or to any other component of the product. NEVER restart EPZICOM or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B*5701 status [see Warnings and Precautions (5.1), Adverse Reactions (6)].*hepatic impairment [see Use in Specific Populations (8.7)].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1139e7f-2db9-4961-9da3-9b7f2088736f#section-11.3 | publisher = | date = | accessdate = 10 January 2014 }}</ref> | *previously demonstrated hypersensitivity to abacavir or to any other component of the product. NEVER restart EPZICOM or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B | ||
*5701 status [see Warnings and Precautions (5.1), Adverse Reactions (6)].*hepatic impairment [see Use in Specific Populations (8.7)].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f1139e7f-2db9-4961-9da3-9b7f2088736f#section-11.3 | publisher = | date = | accessdate = 10 January 2014 }}</ref> | |||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
Latest revision as of 01:03, 10 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Contraindications
EPZICOM Tablets are contraindicated in patients with:
- previously demonstrated hypersensitivity to abacavir or to any other component of the product. NEVER restart EPZICOM or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B
- 5701 status [see Warnings and Precautions (5.1), Adverse Reactions (6)].*hepatic impairment [see Use in Specific Populations (8.7)].[1]
References
- ↑ "EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]". Retrieved 10 January 2014.
Adapted from the FDA Package Insert.